EBS - Emergent Biosolutions - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

EBS is currently covered by 3 analysts with an average price target of $11. This is a potential upside of $5.95 (117.82%) from yesterday's end of day stock price of $5.05.

Emergent Biosolutions's activity chart (see below) currently has 127 price targets and 105 ratings on display. The stock rating distribution of EBS is 88.89% BUY and 11.11% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 66.86% of the time, taking 98.64 days on average.

Highest price target for EBS is $12, Lowest price target is $10, average price target is $11.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2026. First documented stock forecast 27-Sep-2017.

Currently out of the existing stock ratings of EBS, 8 are a BUY (88.89%), 1 are a SELL (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Dec-2024

$10

$4.95 (98.02%)

$10

2 months 13 days ago
(09-Sep-2026)

0/17 (0%)

$4.32 (76.06%)

Sell Since 20-Nov-2023

3 months 1 days ago
(21-Aug-2026)

2/3 (66.67%)

$0.88 (10.84%)

7

Buy Since 11-Apr-2024

$12

$6.95 (137.62%)

$12

5 months 20 days ago
(02-Jun-2026)

7/14 (50%)

$3.79 (46.16%)

72

Buy Since 13-Sep-2024

$16

$23

2 years 2 months 9 days ago
(13-Sep-2024)

11/16 (68.75%)

$8.13 (103.30%)

123

Hold Since 12-Sep-2022

$15

$29

3 years 6 months 3 days ago
(19-May-2023)

4/8 (50%)

$6.83 (83.60%)

86

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EBS (Emergent Biosolutions) average time for price targets to be met?

On average it took 99 days for the stock forecasts to be reached, with an average price target met ratio of 66.86%.

Which analyst most recently updated their price target on EBS (Emergent Biosolutions)?

Raghuram Selvaraju

Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 12 price targets and 12 ratings on EBS

Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?

Dana Flanders with the highest potential upside of $104.95

Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?

David Maris with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?